These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Managing ulcerative and granulomatous bowel disorders. Geduldig MM Am Fam Physician; 1971 Nov; 4(5):100-9. PubMed ID: 5000697 [No Abstract] [Full Text] [Related]
6. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
7. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases]. Kruis W; Pohl C Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288 [No Abstract] [Full Text] [Related]
19. Is histology useful for the assessment of the efficacy of immunosuppressive agents in IBD and if so, how should it be applied ? Geboes K Acta Gastroenterol Belg; 2004; 67(3):285-9. PubMed ID: 15587337 [TBL] [Abstract][Full Text] [Related]
20. Natural history of inflammatory bowel disease patients submitted to solid organ transplantation. Salgueiro P; Lago P; Pedroto I J Crohns Colitis; 2013 Jun; 7(5):e196. PubMed ID: 23265764 [No Abstract] [Full Text] [Related] [Next] [New Search]